![Current status of immunotherapy in metastatic colorectal cancer | International Journal of Colorectal Disease Current status of immunotherapy in metastatic colorectal cancer | International Journal of Colorectal Disease](https://media.springernature.com/m685/springer-static/image/art%3A10.1007%2Fs00384-018-3202-8/MediaObjects/384_2018_3202_Fig1_HTML.png)
Current status of immunotherapy in metastatic colorectal cancer | International Journal of Colorectal Disease
![Chemo-immunotherapy of colon cancer with focused ultrasound and Salmonella-laden temperature sensitive liposomes (thermobots) | Scientific Reports Chemo-immunotherapy of colon cancer with focused ultrasound and Salmonella-laden temperature sensitive liposomes (thermobots) | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-018-30106-4/MediaObjects/41598_2018_30106_Fig1_HTML.png)
Chemo-immunotherapy of colon cancer with focused ultrasound and Salmonella-laden temperature sensitive liposomes (thermobots) | Scientific Reports
Colorectal Cancer Canada - Immunotherapy involves priming the host's natural immune defenses to recognize, target, and destroy cancer cells effectively. Immunotherapy is introduced when your tumor can't be successfully removed with surgery
![Cureus | A Review of 10-Year Survivability of Immunotherapy in the Management of Colon Cancer | Article Cureus | A Review of 10-Year Survivability of Immunotherapy in the Management of Colon Cancer | Article](https://assets.cureus.com/uploads/figure/file/673548/article_river_139f7750161b11eeb0e33b093c51ab47-Prisma-for-colon-cancer.png)
Cureus | A Review of 10-Year Survivability of Immunotherapy in the Management of Colon Cancer | Article
![Frontiers | Neoadjuvant Immunotherapy for MSI-H/dMMR Locally Advanced Colorectal Cancer: New Strategies and Unveiled Opportunities Frontiers | Neoadjuvant Immunotherapy for MSI-H/dMMR Locally Advanced Colorectal Cancer: New Strategies and Unveiled Opportunities](https://www.frontiersin.org/files/Articles/795972/fimmu-13-795972-HTML/image_m/fimmu-13-795972-g001.jpg)
Frontiers | Neoadjuvant Immunotherapy for MSI-H/dMMR Locally Advanced Colorectal Cancer: New Strategies and Unveiled Opportunities
![Immunotherapy in colorectal cancer: rationale, challenges and potential | Nature Reviews Gastroenterology & Hepatology Immunotherapy in colorectal cancer: rationale, challenges and potential | Nature Reviews Gastroenterology & Hepatology](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41575-019-0126-x/MediaObjects/41575_2019_126_Fig3_HTML.png)
Immunotherapy in colorectal cancer: rationale, challenges and potential | Nature Reviews Gastroenterology & Hepatology
![Clinical benefits of PD-1/PD-L1 inhibitors in patients with metastatic colorectal cancer: a systematic review and meta-analysis | World Journal of Surgical Oncology | Full Text Clinical benefits of PD-1/PD-L1 inhibitors in patients with metastatic colorectal cancer: a systematic review and meta-analysis | World Journal of Surgical Oncology | Full Text](https://media.springernature.com/m685/springer-static/image/art%3A10.1186%2Fs12957-022-02549-7/MediaObjects/12957_2022_2549_Fig1_HTML.png)
Clinical benefits of PD-1/PD-L1 inhibitors in patients with metastatic colorectal cancer: a systematic review and meta-analysis | World Journal of Surgical Oncology | Full Text
![Advances and new frontiers for immunotherapy in colorectal cancer: Setting the stage for neoadjuvant success?: Molecular Therapy - Oncolytics Advances and new frontiers for immunotherapy in colorectal cancer: Setting the stage for neoadjuvant success?: Molecular Therapy - Oncolytics](https://www.cell.com/cms/attachment/62e94f0b-1c29-4445-8a86-0afc4b303cdc/gr3_lrg.jpg)
Advances and new frontiers for immunotherapy in colorectal cancer: Setting the stage for neoadjuvant success?: Molecular Therapy - Oncolytics
![Clinical trials of neoadjuvant immune checkpoint inhibitors for early-stage operable colon and rectal cancer | Cancer Immunology, Immunotherapy Clinical trials of neoadjuvant immune checkpoint inhibitors for early-stage operable colon and rectal cancer | Cancer Immunology, Immunotherapy](https://media.springernature.com/m685/springer-static/image/art%3A10.1007%2Fs00262-023-03480-w/MediaObjects/262_2023_3480_Fig2_HTML.png)
Clinical trials of neoadjuvant immune checkpoint inhibitors for early-stage operable colon and rectal cancer | Cancer Immunology, Immunotherapy
![Cancers | Free Full-Text | Neoadjuvant Immunotherapy for Patients with dMMR/MSI-High Gastrointestinal Cancers: A Changing Paradigm Cancers | Free Full-Text | Neoadjuvant Immunotherapy for Patients with dMMR/MSI-High Gastrointestinal Cancers: A Changing Paradigm](https://www.mdpi.com/cancers/cancers-15-03833/article_deploy/html/images/cancers-15-03833-g001.png)